New Breakthrough in Anal Cancer Treatment
I am an anal cancer survivor since 2009. I subscribe to an additional Anal Cancer website-The HPV Anal Cancer Foundation. I just received the article from them below and thought I would share with you all.
Mike
Results from a study out of MD Anderson showed that metastatic anal cancer patients had an enormous response rate (24%) to a new immunotherapy compound called Nivolumab. Further, the drug was well tolerated with minimal side effects.
|
|
|
|
Comments
-
Mike
Very hopeful sounding! Thank you!
0 -
New treatment
This sounds like great news! Anyone who is newly diagnosed should share this with their oncologists who may not be up on the latest treatment.
0
Discussion Boards
- All Discussion Boards
- 6 CSN Information
- 6 Welcome to CSN
- 121.2K Cancer specific
- 2.8K Anal Cancer
- 440 Bladder Cancer
- 306 Bone Cancers
- 1.6K Brain Cancer
- 28.4K Breast Cancer
- 391 Childhood Cancers
- 27.9K Colorectal Cancer
- 4.6K Esophageal Cancer
- 1.2K Gynecological Cancers (other than ovarian and uterine)
- 12.9K Head and Neck Cancer
- 6.3K Kidney Cancer
- 666 Leukemia
- 789 Liver Cancer
- 4.1K Lung Cancer
- 5.1K Lymphoma (Hodgkin and Non-Hodgkin)
- 235 Multiple Myeloma
- 7.1K Ovarian Cancer
- 53 Pancreatic Cancer
- 486 Peritoneal Cancer
- 5.3K Prostate Cancer
- 1.2K Rare and Other Cancers
- 532 Sarcoma
- 717 Skin Cancer
- 647 Stomach Cancer
- 190 Testicular Cancer
- 1.5K Thyroid Cancer
- 5.8K Uterine/Endometrial Cancer
- 6.3K Lifestyle Discussion Boards